NCT00116233

Brief Summary

This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 28, 2005

Completed
Last Updated

June 28, 2005

Status Verified

June 1, 2005

First QC Date

June 27, 2005

Last Update Submit

June 27, 2005

Conditions

Keywords

post operative adhesions

Interventions

REPEL-CVDEVICE

Eligibility Criteria

Age1 Day - 1 Year
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Stage sternotomies

You may not qualify if:

  • Delayed closure beyond 5 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SyntheMed

Little Silver, New Jersey, 07739, United States

RECRUITING

MeSH Terms

Conditions

Tissue Adhesions

Condition Hierarchy (Ancestors)

CicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Eli Pines

    SyntheMed

    STUDY DIRECTOR

Central Study Contacts

Eli Pines, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

June 27, 2005

First Posted

June 28, 2005

Last Updated

June 28, 2005

Record last verified: 2005-06

Locations